Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction

Summary

Phase I trial to study the effectiveness of erlotinib in treating patients who have unresectable liver cancer and liver dysfunction. Biological therapies such as erlotinib may interfere with the growth of tumor cells and slow the growth of the tumor

Timeline

Start

2002-08

Primary completion

2005-12

Completion

—

Drugs

Indications